Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

2015 The Lancet Infectious Diseases 318 citations

Keywords

SerologyMiddle East respiratory syndrome coronavirusMedicineMiddle East respiratory syndromeCoronavirus disease 2019 (COVID-19)Cross-sectional studyVirologyCoronavirusAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirus InfectionsImmunologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakPathology

Affiliated Institutions

Related Publications

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

Publication Info

Year
2015
Type
article
Volume
15
Issue
5
Pages
559-564
Citations
318
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

318
OpenAlex

Cite This

Marcel A. Müller, Benjamin Meyer, Victor M. Corman et al. (2015). Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. The Lancet Infectious Diseases , 15 (5) , 559-564. https://doi.org/10.1016/s1473-3099(15)70090-3

Identifiers

DOI
10.1016/s1473-3099(15)70090-3